ModelEdge

Scinai Immunotherapeutics Ltd

Filing Type	10-K
Filing Date	4/16/2023
Updated	4/17/23, 10:06 AM

Filing

Earnings Release

Exhibits

EX-3.1ARTICLES OF ASSOCIATION OF BIONDVAX PHARMACEUTICALS LTD

EX-4.1DESCRIPTION OF SECURITIES

EX-10.8ADDENDUM TO EMPLOYMENT AGREEMENT DATED MAY 28, 2015, BETWEEN BIONDVAX PHARMACEUTICALS LTD. AND DR. TAMAR-BEN YEDIDIA

EX-10.9ADDENDUM TO EMPLOYMENT AGREEMENT DATED APRIL 1, 2012, BETWEEN BIONDVAX PHARMACEUTICALS LTD. AND DR. TAMAR-BEN YEDIDIA

EX-10.10EMPLOYMENT AGREEMENT DATED SEPTEMBER 5, 2018, BETWEEN BIONDVAX PHARMACEUTICALS LTD. AND ELAD MARK

EX-10.21AMENDMENT AGREEMENT DATED AUGUST 9, 2022, TO FINANCE CONTRACT DATED JUNE 19, 2017 AND AS AMENDED FROM TIME TO TIME, BY AND BETWEEN BIONDVAX PHARMACEUTICALS LTD. AND THE EUROPEAN INVESTMENT BANK

EX-14.1CODE OF CONDUCT

EX-23.1CONSENT OF KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A MEMBER OF ERNST & YOUNG GLOBAL, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE REGISTRANT

EX-31.1CERTIFICATION

EX-31.2CERTIFICATION

EX-32.1CERTIFICATION

EX-32.2CERTIFICATION